Novo Nordisk: The Sell-Off Is Getting Absolutely Ridiculous

Core Insights - Novo Nordisk (NVO) is facing a significant disconnect between its market capitalization and actual business fundamentals, indicating potential mispricing in the market [1] Company Analysis - The company is not experiencing any decline in its prospects, suggesting that the fundamentals remain strong despite market perceptions [1]